Analyst John Kim from BMO Capital Markets maintains his Market Perform rating for Ventas, Inc. (NYSE:VTR) following its $1.5 billion acquisition of the Wexford life sciences portfolio from Blackstone and a raise in equity of $649 million. The analyst questions Ventas’ shift in strategy to develop into a capital-intense asset type. Although the analyst is skeptical on the stock, he increased his price target by $6 to $69 due to its 10-year yield being at record lows.

According to TipRanks, Kim has a success rate of 58% and an average return of 2.5% per recommendation.